Warning: The NCBI web site requires JavaScript to function. more...
The temporal program of peripheral blood gene expression in the response of nonhuman primates to Ebola hemorrhagic fever.
Rubins KH, Hensley LE, Wahl-Jensen V, Daddario DiCaprio KM, Young HA, Reed DS, Jahrling PB, Brown PO, Relman DA, Geisbert TW.
Genome Biol. 2007;8(8):R174.
Related citations
Proinflammatory response during Ebola virus infection of primate models: possible involvement of the tumor necrosis factor receptor superfamily.
Hensley LE, Young HA, Jahrling PB, Geisbert TW.
Immunol Lett. 2002 Mar 1;80(3):169-79.
Pathogenesis of Ebola hemorrhagic fever in cynomolgus macaques: evidence that dendritic cells are early and sustained targets of infection.
Geisbert TW, Hensley LE, Larsen T, Young HA, Reed DS, Geisbert JB, Scott DP, Kagan E, Jahrling PB, Davis KJ.
Am J Pathol. 2003 Dec;163(6):2347-70.
Pathogenesis of Ebola hemorrhagic fever in primate models: evidence that hemorrhage is not a direct effect of virus-induced cytolysis of endothelial cells.
Geisbert TW, Young HA, Jahrling PB, Davis KJ, Larsen T, Kagan E, Hensley LE.
Am J Pathol. 2003 Dec;163(6):2371-82.
Ebola virus-like particle-based vaccine protects nonhuman primates against lethal Ebola virus challenge.
Warfield KL, Swenson DL, Olinger GG, Kalina WV, Aman MJ, Bavari S.
J Infect Dis. 2007 Nov 15;196 Suppl 2:S430-7.
Therapeutics of Ebola hemorrhagic fever: whole-genome transcriptional analysis of successful disease mitigation.
Yen JY, Garamszegi S, Geisbert JB, Rubins KH, Geisbert TW, Honko A, Xia Y, Connor JH, Hensley LE.
J Infect Dis. 2011 Nov;204 Suppl 3:S1043-52.
The host response to smallpox: analysis of the gene expression program in peripheral blood cells in a nonhuman primate model.
Rubins KH, Hensley LE, Jahrling PB, Whitney AR, Geisbert TW, Huggins JW, Owen A, Leduc JW, Brown PO, Relman DA.
Proc Natl Acad Sci U S A. 2004 Oct 19;101(42):15190-5. Epub 2004 Oct 11.
Evaluation in nonhuman primates of vaccines against Ebola virus.
Geisbert TW, Pushko P, Anderson K, Smith J, Davis KJ, Jahrling PB.
Emerg Infect Dis. 2002 May;8(5):503-7.
Functional CD8+ T cell responses in lethal Ebola virus infection.
Bradfute SB, Warfield KL, Bavari S.
J Immunol. 2008 Mar 15;180(6):4058-66.
Ebola virus: new insights into disease aetiopathology and possible therapeutic interventions.
Geisbert TW, Hensley LE.
Expert Rev Mol Med. 2004 Sep 21;6(20):1-24. Review.
Stimulation of Ebola virus production from persistent infection through activation of the Ras/MAPK pathway.
Strong JE, Wong G, Jones SE, Grolla A, Theriault S, Kobinger GP, Feldmann H.
Proc Natl Acad Sci U S A. 2008 Nov 18;105(46):17982-7. Epub 2008 Nov 3.
Whole-genome expression profiling reveals that inhibition of host innate immune response pathways by Ebola virus can be reversed by a single amino acid change in the VP35 protein.
Hartman AL, Ling L, Nichol ST, Hibberd ML.
J Virol. 2008 Jun;82(11):5348-58. Epub 2008 Mar 19.
Gene-specific countermeasures against Ebola virus based on antisense phosphorodiamidate morpholino oligomers.
Warfield KL, Swenson DL, Olinger GG, Nichols DK, Pratt WD, Blouch R, Stein DA, Aman MJ, Iversen PL, Bavari S.
PLoS Pathog. 2006 Jan;2(1):e1. Epub 2006 Jan 13.
Blood genomic profiles of exposures to Venezuelan equine encephalitis in Cynomolgus macaques (Macaca fascicularis).
Hammamieh R, Barmada M, Ludwig G, Peel S, Koterski N, Jett M.
Virol J. 2007 Aug 29;4:82.
Mechanisms underlying coagulation abnormalities in ebola hemorrhagic fever: overexpression of tissue factor in primate monocytes/macrophages is a key event.
Geisbert TW, Young HA, Jahrling PB, Davis KJ, Kagan E, Hensley LE.
J Infect Dis. 2003 Dec 1;188(11):1618-29. Epub 2003 Nov 14.
Ebola hemorrhagic fever: evaluation of passive immunotherapy in nonhuman primates.
Jahrling PB, Geisbert JB, Swearengen JR, Larsen T, Geisbert TW.
J Infect Dis. 2007 Nov 15;196 Suppl 2:S400-3.
Differences in global gene expression in peripheral blood mononuclear cells indicate a significant role of the innate responses in progression of dengue fever but not dengue hemorrhagic fever.
Ubol S, Masrinoul P, Chaijaruwanich J, Kalayanarooj S, Charoensirisuthikul T, Kasisith J.
J Infect Dis. 2008 May 15;197(10):1459-67.
Ectodomain shedding of the glycoprotein GP of Ebola virus.
Dolnik O, Volchkova V, Garten W, Carbonnelle C, Becker S, Kahnt J, Ströher U, Klenk HD, Volchkov V.
EMBO J. 2004 May 19;23(10):2175-84. Epub 2004 Apr 22.
Implication of a retrovirus-like glycoprotein peptide in the immunopathogenesis of Ebola and Marburg viruses.
Yaddanapudi K, Palacios G, Towner JS, Chen I, Sariol CA, Nichol ST, Lipkin WI.
FASEB J. 2006 Dec;20(14):2519-30. Epub 2006 Oct 5.
Early immune responses accompanying human asymptomatic Ebola infections.
Leroy EM, Baize S, Debre P, Lansoud-Soukate J, Mavoungou E.
Clin Exp Immunol. 2001 Jun;124(3):453-60.
Filter your results:
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on